Litcius/Paper detail

Final Analysis of Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression Trial - A Randomized Study of Stereotactic Body Radiotherapy for Oligoprogressive Metastatic Lung and Breast Cancers

C. Jillian Tsai, J.T. Yang, D.M. Guttmann, N. Shaverdian, J. Eng, R. Yeh, J. Girshman, J. Das, D. Gelblum, A.J. Xu, A. Namakydoust, A. Iqbal, J.M. Mann, I. Preeshagul, C. Hajj, E.F. Gillespie, S. Modi, Chunling Dang, P. Drullinsky, wang zhi, Q. LaPlant, A. Rimner, Junghoon Shin, A.J. Wu, Jack Kit‐Chung Ng, A. Gucalp, Ayaan Khan, R. Sanford, J. Bromberg, A.D. Seidman, T.A. Traina, D.R. Gomez, J. Flynn, Z. Zhang, J.A. Patel, M. Berger, J.S. Reis-Filho, N.Y. Lee, N. Riaz, M.E. Robson, C.M. Rudin, S.N. Powell

2022International Journal of Radiation Oncology*Biology*Physics37 citationsDOI

Topics & Concepts

MedicineClinical endpointOncologyMetastatic breast cancerBreast cancerInternal medicineLung cancerRandomized controlled trialRadiation therapyCancerLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesLung Cancer Treatments and Mutations
Final Analysis of Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression Trial - A Randomized Study of Stereotactic Body Radiotherapy for Oligoprogressive Metastatic Lung and Breast Cancers | Litcius